InMed Pharmaceuticals’ New Alzheimer’s Treatment Patent
Company Announcements

InMed Pharmaceuticals’ New Alzheimer’s Treatment Patent

Story Highlights

InMed Pharmaceuticals (INM) has released an update.

InMed Pharmaceuticals has filed an international patent application for INM-901, a small molecule drug candidate aimed at treating neurodegenerative diseases like Alzheimer’s. The drug shows promise in reducing neuroinflammation and improving cognitive function, positioning it as a potentially significant advancement in treating these conditions.

For further insights into INM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskInMed Pharmaceuticals Showcases INM-901 at Biotech Webinar
TipRanks Auto-Generated NewsdeskInMed Pharmaceuticals Strengthens Team with Alzheimer’s Expert
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App